دورية أكاديمية
Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache. ; Lignes de conduite de la Société Internationale des Céphalées pour les essais cliniques dans l'algie vasculaire de la face
العنوان: | Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache. ; Lignes de conduite de la Société Internationale des Céphalées pour les essais cliniques dans l'algie vasculaire de la face |
---|---|
المؤلفون: | Schoenen, Jean, Snoer, Agneta Henriette, Brandt, Roemer B, Fronczek, Rolf, Wei, Diana Y, Chung, Chin-Sang, Diener, Hans-Christoph, Dodick, David W, Fontaine, Denys, Goadsby, Peter J, Matharu, Manjit Singh, May, Arne, McGinley, James S, Tepper, Stewart J, Jensen, Rigmor Højland, Ferrari, Michel D, IHS Standing Committee for Clinical Trials, IHS cluster headache trial guideline subcommittee |
المساهمون: | Unité de Recherche sur les Céphalées |
المصدر: | Cephalalgia: an international journal of headache, 42 (14), 1450 - 1466 (2022-12) |
بيانات النشر: | NLM (Medline) |
سنة النشر: | 2022 |
المجموعة: | University of Liège: ORBi (Open Repository and Bibliography) |
مصطلحات موضوعية: | Guidelines, ICHD-3, classifications, cluster headache, Humans, Headache/therapy, Controlled Clinical Trials as Topic, Cluster Headache/drug therapy, Headache, Neurology (clinical), General Medicine, Human health sciences, Neurology, Sciences de la santé humaine, Neurologie |
الوصف: | peer reviewed ; In 1995, a committee of the International Headache Society developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Cluster Headache. These have not been revised. With the emergence of new medications, neuromodulation devices and trial designs, an updated version of the International Headache Society Guidelines for Controlled Clinical Trials in Cluster Headache is warranted. Given the scarcity of evidence-based data for cluster headache therapies, the update is largely consensus-based, but takes into account lessons learned from recent trials and demands by patients. It is intended to apply to both drug and neuromodulation treatments, with specific proposals for the latter when needed. The primary objective is to propose a template for designing high quality, state-of-the-art, controlled clinical trials of acute and preventive treatments in episodic and chronic cluster headache. The recommendations should not be regarded as dogma and alternative solutions to particular methodological problems should be explored in the future and scientifically validated. |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
تدمد: | 0333-1024 1468-2982 |
العلاقة: | urn:issn:0333-1024; urn:issn:1468-2982; https://orbi.uliege.be/handle/2268/297312Test; info:hdl:2268/297312; scopus-id:2-s2.0-85142918615; info:pmid:36268950 |
DOI: | 10.1177/03331024221120266 |
الإتاحة: | https://doi.org/10.1177/03331024221120266Test https://orbi.uliege.be/handle/2268/297312Test |
حقوق: | restricted access ; http://purl.org/coar/access_right/c_16ecTest ; info:eu-repo/semantics/restrictedAccess |
رقم الانضمام: | edsbas.88D1C370 |
قاعدة البيانات: | BASE |
تدمد: | 03331024 14682982 |
---|---|
DOI: | 10.1177/03331024221120266 |